Marker Therapeutics, Inc. (MRKR) Insider Trading Activity

NASDAQ$1.7
Market Cap
$19.24M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
111 of 863
Rank in Industry
74 of 492

MRKR Insider Trading Activity

MRKR Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$1,809,072
2
100
Sells
$0
0
0

Related Transactions

New Enterprise Associates 16, L.P.10 percent owner
1
$1.77M
0
$0
$1.77M
ELMS STEVEdirector
1
$35,472
0
$0
$35,472

About Marker Therapeutics, Inc.

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells expressing tumor-associated antigens. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, and various solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; and off-the-shelf products in various indications. It is also developing TPIV100/110, a peptide-based immunotherapeutic vaccines for the treatment of breast and ovarian cancer cells; and TPIV200, which is in Phase 2 clinical trial for the treatment of breast and ovarian cancers. The company was founded in 1999 and is headquartered in Houston, Texas.

Insider Activity of Marker Therapeutics, Inc.

Over the last 12 months, insiders at Marker Therapeutics, Inc. have bought $1.81M and sold $0 worth of Marker Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Marker Therapeutics, Inc. have bought $54.17M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: New Enterprise Associates 16, L.P. (10 percent owner) — $1.77M. ELMS STEVE (director) — $35,472.

The last purchase of 554,250 shares for transaction amount of $1.77M was made by New Enterprise Associates 16, L.P. (10 percent owner) on 2024‑12‑23.

List of Insider Buy and Sell Transactions, Marker Therapeutics, Inc.

2024-12-23PurchaseNew Enterprise Associates 16, L.P.10 percent owner
554,250
5.7713%
$3.20
$1.77M
-55.85%
2024-12-23PurchaseELMS STEVEdirector
11,085
0.1154%
$3.20
$35,472
-55.85%
2021-05-18PurchaseWasserman Frederick Geralddirector
10,000
0.0119%
$2.41
$24,098
-43.03%
2021-03-16PurchaseWalker Paul Edward10 percent owner
5.71M
9.5207%
$1.75
$10M
-4.30%
2021-03-16PurchaseSonsini Peter W.10 percent owner
5.71M
9.5207%
$1.75
$10M
-4.30%
2021-03-16PurchaseSANDELL SCOTT D10 percent owner
5.71M
9.5207%
$1.75
$10M
-4.30%
2021-03-16PurchaseNew Enterprise Associates 16, L.P.10 percent owner
5.71M
9.5207%
$1.75
$10M
-4.30%
2021-03-16PurchaseMAKOWER JOSHUA10 percent owner
5.71M
9.5207%
$1.75
$10M
-4.30%
2021-03-16PurchaseMakhzoumi Mohamad10 percent owner
5.71M
9.5207%
$1.75
$10M
-4.30%
2021-03-16PurchaseFlorence Anthony A. Jr.10 percent owner
5.71M
9.5207%
$1.75
$10M
-4.30%
2021-03-16PurchaseChang Carmen10 percent owner
5.71M
9.5207%
$1.75
$10M
-4.30%
2021-03-16PurchaseBehbahani Ali10 percent owner
5.71M
9.5207%
$1.75
$10M
-4.30%
2021-03-16PurchaseBASKETT FOREST10 percent owner
5.71M
9.5207%
$1.75
$10M
-4.30%
2021-03-16PurchaseWilson John Robertdirector
1.71M
2.8562%
$1.75
$3M
-4.30%
2021-03-16PurchaseELMS STEVEdirector
1.14M
1.9041%
$1.75
$2M
-4.30%
2021-03-16PurchaseVera JuanChief Development Officer
571,428
0.9521%
$1.75
$999,999
-4.30%
2021-03-16PurchaseHoang Peter L.President and CEO
142,857
0.238%
$1.75
$250,000
-4.30%
2021-03-16PurchaseEansor Norman Daviddirector
14,285
0.238%
$17.50
$249,988
-4.30%
2019-08-14PurchaseHoang Peter L.President and CEO
10,000
0.0219%
$4.62
$46,200
-41.13%
2018-05-14PurchaseEastern Capital LTD10 percent owner
2.6M
17.57%
$2.40
$6.24M
+127.00%
Total: 21
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
New Enterprise Associates 16, L.P.10 percent owner
1625678
14.3677%
$2.76M20
<0.0001%
ELMS STEVEdirector
325370
2.8756%
$553,129.0020
<0.0001%
MAKOWER JOSHUA10 percent owner
10714285
94.6927%
$18.21M10
<0.0001%
SANDELL SCOTT D10 percent owner
10714285
94.6927%
$18.21M10
<0.0001%
BASKETT FOREST10 percent owner
10714285
94.6927%
$18.21M10
<0.0001%
Walker Paul Edward10 percent owner
10714285
94.6927%
$18.21M10
<0.0001%
Sonsini Peter W.10 percent owner
10714285
94.6927%
$18.21M10
<0.0001%
Florence Anthony A. Jr.10 percent owner
10714285
94.6927%
$18.21M10
<0.0001%
Behbahani Ali10 percent owner
10714285
94.6927%
$18.21M10
<0.0001%
Makhzoumi Mohamad10 percent owner
10714285
94.6927%
$18.21M10
<0.0001%
Chang Carmen10 percent owner
10714285
94.6927%
$18.21M10
<0.0001%
Wilson John Robertdirector
7799350
68.9305%
$13.26M10
<0.0001%
Eastern Capital LTD10 percent owner
5300002
46.8413%
$9.01M10
+127%
Vera JuanChief Development Officer
2564487
22.6649%
$4.36M10
<0.0001%
Hoang Peter L.President and CEO
332568
2.9392%
$565,365.6020
<0.0001%
CORIN DENISPresident and CFO
135300
1.1958%
$230,010.0001
Wasserman Frederick Geralddirector
52565
0.4646%
$89,360.5010
<0.0001%
Eansor Norman Daviddirector
16713
0.1477%
$28,412.1010
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$53,490,060
55
19.35%
$19.52M
$1,443,732
36
10.14%
$21.07M
$226,127
22
-27.62%
$16.85M
$555,628
21
43.52%
$16.67M
$114,405,653
19
-5.40%
$15.93M
Marker Therapeutics, Inc.
(MRKR)
$112,810,270
18
-1.20%
$19.24M
$79,536,861
15
-6.81%
$20.56M
$25,487,383
15
-4.37%
$21.6M
$122,973
15
-26.96%
$19.25M
$39,336,371
14
-17.87%
$17.89M
$1,199,157
14
7.52%
$19.15M
$389,864
11
12.52%
$19.33M
$20,715,938
10
-42.51%
$19.33M
$11,777,042
10
-11.94%
$17.1M
$309,830
10
-55.78%
$19.56M
$2,060,158
5
-21.35%
$16.69M
$82,917
4
-11.54%
$18.42M
$31,190
2
-14.18%
$20.35M
$19,863
1
144.27%
$15.51M

MRKR Institutional Investors: Active Positions

Increased Positions13+40.63%360,931+8.07%
Decreased Positions9-28.13%737,308-16.48%
New Positions3New88,640New
Sold Out Positions3Sold Out33,389Sold Out
Total Postitions36+12.5%4M-8.41%

MRKR Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Nea Management Company, Llc$2,032.0014.78%1.63M+554,250+51.73%2024-12-31
Alyeska Investment Group, L.P.$1,144.008.32%915,591+915,591New2024-12-31
Blue Owl Capital Holdings Lp$693.005.04%554,250+554,250New2024-12-31
Hudson Bay Capital Management Lp$415.003.02%331,670+331,670New2024-12-31
Aisling Capital Management Lp$407.002.96%325,370+11,084+3.53%2024-12-31
Vanguard Group Inc$304.002.21%243,12200%2024-12-31
Lpl Financial Llc$100.000.73%79,730+79,730New2024-12-31
Geode Capital Management, Llc$95.000.69%75,680+4,119+5.76%2024-12-31
Ar Asset Management Inc$92.000.67%73,70000%2024-12-31
Northern Trust Corp$68.000.49%54,156+21,703+66.88%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.